These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 230621)

  • 1. Clinical results on the use of human ceruloplasmin in aplastic anemia.
    Shimizu M
    Transfusion; 1979; 19(6):742-8. PubMed ID: 230621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Folic acid and ceruloplasmin].
    Shimizu M
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):179-80. PubMed ID: 5530037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Hypoplastic anemia with ceruloplasmin--discussions on its effectiveness and mechanism (author's transl)].
    Hoshino T; Uchida A; Takahashi T; Horiuchi T
    Rinsho Ketsueki; 1980 Apr; 21(4):498-505. PubMed ID: 7411880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment and prognosis of aplastic anemia].
    Hiraki K; Mori S
    Saishin Igaku; 1969 Apr; 24(4):749-56. PubMed ID: 4185455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences in therapy of aplastic anemias using oxymetholone].
    Michlmayr G; Huber C; Judmaier G; Huber H
    Dtsch Med Wochenschr; 1973 May; 98(20):1026-8 passim. PubMed ID: 4707649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-laboratory variants of the course and results of therapy of hepatitis-associated aplastic anemias in children].
    Novichkova GA; Maschan MA; Kravchenko EG; Baĭdil'dina DD; Bogacheva NIu; Goronkova OV; Zharikova LI; Litvinov DV; Solopova GG; Suntsova EV; Shneĭder MM; Khachatrian LA; Skorobogatova EV; Shipitsyna IP; Trakhtman PE; Balashov DN; Maschan AA
    Ter Arkh; 2007; 79(7):57-61. PubMed ID: 17802792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of serum enzyme determinations in assessing therapeutic effect of steroid hormones in epidemic hepatitis.
    Borisova MA
    Fed Proc Transl Suppl; 1966; 25(4):704-6. PubMed ID: 5223521
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of rHuEPO on aplastic anemia: results of a phase II clinical study].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Sep; 34(9):1002-10. PubMed ID: 8230742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir in the treatment of aplastic anemia.
    Gómez-Almaguer D; Marfil-Rivera J; Kudish-Wersh A
    Am J Hematol; 1988 Nov; 29(3):172-3. PubMed ID: 3189312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aplastic anemia in children.
    Diamond LK; Shahidi NT
    Semin Hematol; 1967 Jul; 4(3):278-88. PubMed ID: 4294607
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens.
    Bukowczyk A; Radzikowska J
    Pol Med J; 1971; 10(1):227-38. PubMed ID: 5573906
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
    Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K
    Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Quinton/Scribner arteriovenous shunt in management of aplastic anaemias.
    Williams BT; Blainey JD; Dawson-Edwards P; Hilton DD; Simpson KM
    Br Med J; 1967 May; 2(5550):484-5. PubMed ID: 6023968
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigation on clinical feature and treatment of aplastic anemia remitted in a short period (author's transl)].
    Yonahara Y; Ito M
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):563-70. PubMed ID: 4799451
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of aplastic anemia with immunosuppressive agents.
    Takaku F
    Tokai J Exp Clin Med; 1986; 11 Suppl():197-204. PubMed ID: 3452242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.
    Lengline E; Drenou B; Peterlin P; Tournilhac O; Abraham J; Berceanu A; Dupriez B; Guillerm G; Raffoux E; de Fontbrune FS; Ades L; Balsat M; Chaoui D; Coppo P; Corm S; Leblanc T; Maillard N; Terriou L; Socié G; de Latour RP
    Haematologica; 2018 Feb; 103(2):212-220. PubMed ID: 29170252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [B and T lymphocyte subpopulations in peripheral blood and bone marrow blood from aplastic anemia in childhood (author's transl)].
    Nakagawa T; Yata J; Nakayama K
    Rinsho Ketsueki; 1975 Sep; 16(9):850-8. PubMed ID: 175190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of Shenmai injection on blood serum tumor necrosis factor and bone marrow CD34+ cell's apoptosis of chronic aplastic anemia patient].
    Tang Q; Hu H; Zhang H
    Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1296-8. PubMed ID: 16245914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of the toxic effect of the antitumor antibiotic carminomycin].
    Vertogradova TP; Gol'dberg LE; Filippos'iants ST; Belova IP; Stepanova ES
    Antibiotiki; 1974 Jan; 19(1):50-7. PubMed ID: 4463840
    [No Abstract]   [Full Text] [Related]  

  • 20. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.